Vicarious Surgical Inc (RBOT)
0.4063
+0.05
(+14.29%)
USD |
NYSE |
May 22, 16:00
0.40
-0.01
(-1.55%)
After-Hours: 20:00
Vicarious Surgical Cash from Financing (TTM): 44.43M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 44.43M |
December 31, 2023 | 44.70M |
September 30, 2023 | 53.48M |
June 30, 2023 | 9.347M |
March 31, 2023 | 9.244M |
Date | Value |
---|---|
December 31, 2022 | 9.145M |
September 30, 2022 | -0.153M |
June 30, 2022 | 190.81M |
March 31, 2022 | 190.79M |
December 31, 2021 | 192.16M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.153M
Minimum
Sep 2022
192.16M
Maximum
Dec 2021
74.40M
Average
44.57M
Median
Cash from Financing (TTM) Benchmarks
Ekso Bionics Holdings Inc | -- |
Perspective Therapeutics Inc | 167.19M |
Xtant Medical Holdings Inc | 20.30M |
Asensus Surgical Inc | 10.92M |
Catheter Precision Inc | -0.158M |